Expert Insight For Every Medical Technology Investment Banking Transaction
Healthy Outcomes for Mergers & Acquisitions, Capital Raising and More.
In the medical technology sector, it takes a highly focused approach to execute a transaction efficiently. And it requires the constant monitoring of new procedures, technology and product development, and overall market trends. At PMCF, our Medical Technology team brings this dedication and market knowledge to every transaction. Our transaction expertise in the medical device, bio-pharmaceutical, and health care sectors, combined with industry relationships and a proprietary healthcare consulting service offering, afford us a unique perspective in the industry. Our activities include capital raising, growth capital, targeted acquisition search, intellectual property / product line divestitures, strategic sale advisory, and strategic planning consulting.
We are active in several industry segments, including:
- Medical devices
- Contract research / Contract manufacturing
- Drug delivery
Our Specialists in this Sector
Mr. Hughes is a Director of P&M Corporate Finance and leads the firm’s Medical Technology team. He has over 10 years of business and transaction advisory experience, specializing in assisting clients with mergers and acquisitions, leveraged buyouts, private placements, financings, valuation and strategic consulting. Bryan’s clients have ranged from global life sciences companies to small, privately held businesses. In addition to leading the firm’s Medical Technology team, he has also completed transactions in business services, consumer and industrial sectors.
Mr. Hughes earned a B.B.A . with emphasis in finance from the Stephen M. Ross School of Business at the University of Michigan. He is a licensed securities representative, holding Series 7 and 63 registrations. He has written numerous articles and is a frequent speaker on healthcare investment banking topics.